ArticleEmerging microbes & infections2022

Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study.

Jingwen Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.